Continuing Medical Education Videos

Description:

The Evidence-Based Drug Therapy Updates assist primary care providers with the how, when, and why to consider the application of new knowledge and/or new medication where appropriate based upon the evidence that is available at the time. The primary goal is to provide practitioners with the most appropriate-up-to-date, cost-effective, and evidence based pharmacotherapy information so that the information can be applied to the care of their patients. 

 

Overview: The Evidence-Based Drug Therapy Updates are a series of 5 video presentations for CME credit on updates in the evaluation and treatment of patients for the following:

1. Update in the Evaluation and Treatment of COPD

a. The COPD enduring material focuses on how to diagnose COPD and the treatment available, including, smoking cessation, exacerbation reduction, broncodilators, inhaled corticosteroids, and volume reduction. Learners will be better able to: develop the diagnostic strategy to establish a diagnosis of COPD; recognize the different classes of new medications and devices to treat and manage COPD; and discuss the appropriate use of the specific medications approved for COPD in the past two years.

b. Visit the following link for the video: http://flintbox.com/public/project/26609/

2. Geriatric updates in drug therapy for Alzheimer's disease, urinary incontinence, and prevention of falls

a. The geriatric enduring material addresses the top ten things to know about dementia and top ten things to know about the incontinence care. Learners will be better able to: identify at least two reasons to consider using newer anticholinergic medications for treatment of overactive bladder; and list three reasons to administer a brief test of mental status to older adults.

b. Visit the following link for the video: http://flintbox.com/public/project/26610/

3. Updates on a variety of new drugs and comparing and contrasting newer agents to existing therapies

a. Learners will be better able to: discuss the FDA Warnings and label changes that relate to medication safety and apply this information in the selection and monitoring of evidence-based pharmacotherapy to achieve better patient related outcomes; describe the new evidence-based guidelines that need to be considered when making recommendations for specific patients with specific chronic; describe the current information concerning newly FDA approved medications in the selection of evidence-based pharmacotherapy; and compare and contrast these selected newer agents to the existing therapies and recommend an appropriate medication regimen for a specific patient

b. Visit the following link for the video: http://flintbox.com/public/project/26615/

 

4. Prevention of stroke in patients with atrial fibrillation: How to choose an anti-coagulant

a. Learners will be better able to: identify the components of the CHADS2 and CHA2DS2VASC thromboembolic risk scores; discuss the HAS-BLED risk scores and their role in managing patients with atrial fibrillation; explain the treatment guideline recommendations based on the thromboembolic risk scores; describe the differences between the various anticoagulants and considerations for choosing one over another; review recommendations for switching from one anticoagulant to another; and apply the general guidelines for peri-procedural management in patients on oral anticoagulant.

b. Visit the following link for the video: http://flintbox.com/public/project/26614/

5. Update on Type 2 Diabetes

a. The diabetes enduring material provides an update of diabetes, including prevention, standards of medical care, and management of patients with Type 2 Diabetes. Learners will be better able to: explain the relationship between obesity and the risk of Type 2 diabetes and the benefits of lifestyle modification in reducing the risk and helping to prevent and manage patients with Type 2 diabetes; describe the current 2014 ADA Standards of Medical Care for the diagnosis and management of diabetes mellitus; translate the data on the newer FDA approved medications for the management of Type 2 diabetes; and discuss the appropriate use of evidence-based and cost effective therapies in the management of patients with Type 2 diabetes mellitus.

b. Visit the following link for the video: http://flintbox.com/public/project/26612/

 

Credit Designation

Physicians: The Medical University of South Carolina designates this enduring material for a maximum of1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit: Most states accept CMEs that apply to specific nursing specialty as nursing continuing education.  Please check with your respective State Board of Nursing to ascertain the equivalent number of contact hours offered for 1.0 AMA PRA Category 1 Credit(s)™.

All Participants: The Medical University of South Carolina will award .1 CEU (1 contact hour) for viewing the video and passing the posttest. (1 contact hour equals .1 CEU).

 

Applications: Interprofessional education or clinical planning purposes

Key Words: CME, CME credit, pharmacotherapy, drug therapy, COPD, evidence-based medicine, Alzheimer’s disease, urinary incontinence, prevention of falls, dementia

 

Inventors: William M. Simpson, Jr., MD       

Patent Status:        Copyright              

MUSC-FRD Technology ID: P1549a

 

Patent Information:
Category(s):
Copyright
For Information, Contact:
Marketing / Licensing Officer
Marketing/Licensing Officer
MUSC Foundation for Research Development
technology@musc.edu
Inventors:
Keywords:
© 2017. All Rights Reserved. Powered by Inteum